Page results
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients who have been given a walking boot, including air cast boots, pneumatic walking boots and vacoped boots.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
File results
-
FOI/2021/0353 - Operational Pressures Escalation Levels (OPEL) Policy
-
FOI/2021/0363 - Robot assisted laparascopic prostatectomy cost
-
FOI/2021/0367 - Religious accommodation
-
FOI/2021/0369 - Telecommunications
-
FOI/2021/0377 - Stonewall diversity applications
-
FOI/2021/0381 - International nursing agency spend
-
FOI/2021/0388 - Digital dictation/ Voice recognition system
-
FOI/2021/0409 - Service Manager for Paediatric Audiology department
-
FOI/2021/0413 - Service providers for patient, transport and private ambulance
-
FOI/2021/0414 - Cyber attacks